MTHPC-mediated photodynamic treatment up-regulates the cytokines VEGF and IL-1alpha

Photochemistry and Photobiology

Volumn 88, Issue 2, 2012, Pages 432-439

  Dabkeviciene, Daiva ^a   Sasnauskiene, Ausra ^a   Leman, Eva ^a,d   Kvietkauskaite, Raimonda ^b   Daugelaviciene, Neringa ^a   Stankevicius, Vaidotas ^a   Jurgelevicius, Vaclovas ^c   Juodka, Benediktas ^a   Kirveliene, Vida ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Centre of Innovative Medicine   (Lithuania)

^c Lithuanian Veterinary Academy   (Lithuania)

^d UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; MESOPORPHYRIN; PHOTOSENSITIZING AGENT; SMALL INTERFERING RNA; TEMOPORFIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; LIGHT; METABOLISM; PHOTOCHEMOTHERAPY; POLYMERASE CHAIN REACTION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTERLEUKIN-1ALPHA; LIGHT; MESOPORPHYRINS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

TETRA;

EID: 84858002322     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.01062.x     Document Type: Article

References (43)

1. Dougherty, T. J., (1984) Photodynamic therapy (PDT) of malignant tumors. Crit. Rev. Oncol. Hematol. 2, 83-116.
2. Choudhary, S., K. Nouri, and, M. L. Elsaie, (2009) Photodynamic therapy in dermatology: A review. Lasers Med. Sci. 24, 971-980.
3. Allison, R. R., V. S. Bagnato, and, C. H. Sibata, (2010) Future of oncologic photodynamic therapy. Future Oncol. 6, 929-940.
4. Weishaupt, K. R., C. J. Gomer, and, T. J. Dougherty, (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 36, 2326-2329.
5. Dysart, J. S., G. Singh, and, M. S. Patterson, (2005) Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem. Photobiol. 81, 196-205. (Pubitemid 40327580)
6. Gollnick, S. O., S. S. Evans, H. Baumann, B. Owczarczak, P. Maier, L. Vaughan, W. C. Wang, E. Unger, and, B. W. Henderson, (2003) Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88, 1772-1779. (Pubitemid 36760423)
7. Ferrario, A., A. M. Fisher, N. Rucker, and, C. J. Gomer, (2005) Celecoxib and ns-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. 65, 9473-9478. (Pubitemid 41508016)
8. Garg, A. D., D. Nowis, J. Golab, and, P. Agostinis, (2010) Photodynamic therapy: Illuminating the road from cell death towards anti-tumour immunity. Apoptosis 15, 1050-1071.
9. Bonnett, R., R. D. White, U. J. Winfield, and, M. C. Berenbaum, (1989) Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem. J. 261, 277-280. (Pubitemid 19174790)
10. Boyle, R. W., and, D. Dolphin, (1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64, 469-485. (Pubitemid 27039801)
11. Teiten, M. H., L. Bezdetnaya, P. Morliere, R. Santus, and, F. Guillemin, (2003) Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br. J. Cancer 88, 146-152. (Pubitemid 36241232)
12. Triesscheijn, M., M. Ruevekamp, M. Aalders, P. Baas, and, F. A. Stewart, (2004) Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra- hydroxyphenyl-chlorin. Photochem. Photobiol. 80, 236-241.
13. Kirveliene, V., A. Sadauskaite, J. Kadziauskas, S. Sasnauskiene, and, B. Juodka, (2003) Correlation of death modes of photosensitized cells with intracellular ATP concentration. FEBS Lett. 553, 167-172. (Pubitemid 37206345)
14. Marchal, S., A. Fadloun, E. Maugain, M. A. D'Hallewin, F. Guillemin, and, L. Bezdetnaya, (2005) Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochem. Pharmacol. 69, 1167-1176. (Pubitemid 40417488)
15. Sasnauskiene, A., J. Kadziauskas, N. Vezelyte, V. Jonusiene, and, V. Kirveliene, (2009) Apoptosis, autophagy and cell cycle arrest following photodamage to mitochondrial interior. Apoptosis 14, 276-286.
16. O'Connor, A. E., W. M. Gallagher, and, A. T. Byrne, (2009) Porphyrin and nonporphyrin photosensitizers in oncology: Preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol. 85, 1053-1074.
17. Ferrara, N., (2009) VEGF-A: A critical regulator of blood vessel growth. Eur. Cytokine Netw. 20, 158-163.
18. Slaton, J. W., R. Millikan, K. Inoue, T. Karashima, B. Czerniak, Y. Shen, Y. Yang, W. F. Benedict, and, C. P. Dinney, (2004) Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. J. Urol. 171, 570-574. (Pubitemid 38090431)
19. Lee, Y. J., D. L. Karl, U. N. Maduekwe, C. Rothrock, S. Ryeom, P. A. D'Amore, and, S. S. Yoon, (2010) Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment. Cancer Res. 70, 8357-8367.
20. Uehara, M., T. Inokuchi, K. Sano, and, W. ZuoLin, (2001) Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy. Eur. J. Cancer 37, 2111-2115. (Pubitemid 32938117)
21. Bhuvaneswari, R., Y. Y. Gan, K. C. Soo, and, M. Olivo, (2009) The effect of photodynamic therapy on tumor angiogenesis. Cell. Mol. Life Sci. 66, 2275-2283.
22. Zhou, Q., M. Olivo, K. Y. Lye, S. Moore, A. Sharma, and, B. Chowbay, (2005) Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother. Pharmacol. 56, 569-577. (Pubitemid 41425052)
23. Tirand, L., C. Frochot, R. Vanderesse, N. Thomas, E. Trinquet, S. Pinel, M. L. Viriot, F. Guillemin, and, M. Barberi-Heyob, (2006) A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J. Control. Release 111, 153-164. (Pubitemid 43290004)
24. Dinarello, C. A., (1994) The biological properties of interleukin-1. Eur. Cytokine Netw. 5, 517-531.
25. Buryskova, M., M. Pospisek, A. Grothey, T. Simmet, and, L. Burysek, (2004) Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J. Biol. Chem. 279, 4017-4026. (Pubitemid 38198984)
26. Werman, A., R. Werman-Venkert, R. White, J. K. Lee, B. Werman, Y. Krelin, E. Voronov, C. A. Dinarello, and, R. N. Apte, (2004) The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl Acad. Sci. USA 101, 2434-2439. (Pubitemid 38269329)
27. Dvorkin, T., X. Song, S. Argov, R. M. White, M. Zoller, S. Segal, C. A. Dinarello, E. Voronov, and, R. N. Apte, (2006) Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha. J. Leukoc. Biol. 80, 96-106. (Pubitemid 44835530)
28. Ma, J., H. Sawai, Y. Matsuo, N. Ochi, A. Yasuda, H. Takahashi, T. Wakasugi, H. Funahashi, M. Sato, Y. Okada, H. Takeyama, and, T. Manabe, (2008) Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines. J. Surg. Res. 148, 197-204.
29. Koon, H. K., K. W. Lo, K. N. Leung, M. L. Lung, C. C. Chang, R. N. Wong, W. N. Leung, and, N. K. Mak, (2010) Photodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Cell. Mol. Immunol. 7, 323-326.
30. Ito, M., (1984) Microassay for studying anticellular effects of human interferons. J. Interferon Res. 4, 603-608. (Pubitemid 14023315)
31. Sharwani, A., W. Jerjes, C. Hopper, M. P. Lewis, M. El-Maaytah, H. S. Khalil, A. J. Macrobert, T. Upile, and, V. Salih, (2006) Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer. Arch. Oral Biol. 51, 1104-1111. (Pubitemid 44692646)
32. Nakagawa, H., T. Matsumiya, H. Sakaki, T. Imaizumi, K. Kubota, A. Kusumi, W. Kobayashi, and, H. Kimura, (2007) Expression of vascular endothelial growth factor by photodynamic therapy with mono-l-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma. Oral Oncol. 43, 544-550. (Pubitemid 46856261)
33. Niu, J., Z. Li, B. Peng, and, P. J. Chiao, (2004) Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J. Biol. Chem. 279, 16452-16462. (Pubitemid 38509343)
34. Nam, S. Y., Y. S. Ko, J. Jung, J. Yoon, Y. H. Kim, Y. J. Choi, J. W. Park, M. S. Chang, W. H. Kim, and, B. L. Lee, (2011) A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-kappaB promotes gastric tumour growth and angiogenesis. Br. J. Cancer 104, 166-174.
35. Matroule, J. Y., C. Volanti, and, J. Piette, (2006) NF-kappaB in photodynamic therapy: Discrepancies of a master regulator. Photochem. Photobiol. 82, 1241-1246. (Pubitemid 44702003)
36. Ferrario, A., K. F. von Tiehl, N. Rucker, M. A. Schwarz, P. S. Gill, and, C. J. Gomer, (2000) Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60, 4066-4069. (Pubitemid 30636586)
37. Apte, R. N., and, E. Voronov, (2008) Is interleukin-1 a good or bad "guy" in tumor immunobiology and immunotherapy? Immunol. Rev. 222, 222-241. (Pubitemid 351430377)
38. Maier, J. A., M. Statuto, and, G. Ragnotti, (1994) Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell. Biol. 14, 1845-1851. (Pubitemid 24074579)
39. Luheshi, N. M., N. J. Rothwell, and, D. Brough, (2009) The dynamics and mechanisms of interleukin-1alpha and beta nuclear import. Traffic 10, 16-25.
40. Prudovsky, I., F. Tarantini, M. Landriscina, D. Neivandt, R. Soldi, A. Kirov, D. Small, K. M. Kathir, D. Rajalingam, and, T. K. Kumar, (2008) Secretion without Golgi. J. Cell. Biochem. 103, 1327-1343. (Pubitemid 351490704)
41. Sakurai, T., G. He, A. Matsuzawa, G. Y. Yu, S. Maeda, G. Hardiman, and, M. Karin, (2008) Hepatocyte necrosis induced by oxidative stress and il-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14, 156-165.
42. Voronov, E., D. S. Shouval, Y. Krelin, E. Cagnano, D. Benharroch, Y. Iwakura, C. A. Dinarello, and, R. N. Apte, (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA 100, 2645-2650. (Pubitemid 36297552)
43. Planel, S., A. Salomon, P. Jalinot, J. J. Feige, and, N. Cherradi, (2010) A novel concept in antiangiogenic and antitumoral therapy: Multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1. Oncogene 29, 5989-6003.